Blockchain Registration Transaction Record
GeoVax's GEO-CM04S1 Vaccine Shows Superior Protection in Immunocompromised Populations
GeoVax Labs, Inc. announces the effectiveness of GEO-CM04S1 vaccine in immunocompromised populations, aligning with new HHS guidelines. The vaccine offers superior protection and durability, crucial for vulnerable individuals with weakened immune systems.

This news showcases the importance of developing next-generation vaccines tailored to vulnerable populations, such as the immunocompromised. With the shift towards risk-based vaccine strategies, GeoVax's GEO-CM04S1 vaccine offers a promising solution for durable and broad-spectrum immunization, addressing the urgent need for effective COVID-19 protection in high-risk individuals.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x3158f4a5a2b5020a445d2450f1e3d6b07dd3ae82c89db0adbfdaea9e773beec9 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | mildWTnd-003c20357bd70a33eb743d0d592e3dfe |